Search

NEUTRISCI INTERNATIONAL: THE CBD INDUSTRY DISRUPTOR

Updated: 3 days ago




TSX:NU, OTCQB:NRXCF, TOP CBD Technology Stock 2021 Target Price: $1.00 CAD ( 7x Bagger Potential )


Overview: NeutriSci International, the emerging cannabinoid disrupter !


NeutriSci International, TSX:NU, OTCQB:NRXCF, an undervalued, undiscovered, emerging public listed company out of Canada is starting to shake up the CBD industry with its one of a kind technology. In our opinion, it will not only disrupt the sector for years to come, but it will also establish the new gold standard within the global multi-billion dollar cannabinoid industry. We have a winner here that is about to take off. It seems that there are big things happening in the background and we will be discussing this in detail.


We are anticipating the stock to gain massive traction going forward as their industry disrupting technology is about to hit the market. NeutriSci International current market capitalization is less than $25 million CAD, an absolute bargain deal.


Please note that PRC Partners is a shareholder of NeutriSci International (NU.V) and therefore a conflict of interest exists. PRC Partners is not a financial or investment advisor. PRC Partners is not being payed or compensated for this article. Please read our full disclaimer.



What makes NeutriSci International Technology so unique?


NeutriSci International has developed a one of a kind technology & manufacturing process that increases the bioavailability of CBD in the human body. There are two key features that makes their technology unbeatable in the market. As most of you know, cannabinoids are oil-based; therefore, they are difficult to be absorbed by the human body. This is called low bioavailability, and it's a huge problem that the industry is facing. With its patent pending Cryolization process and patented Pterostilbene molecule, NeutriSci is able to drastically increase the bioavailability in the human body. At the same time, NeutriSci can make CBD fully water-soluble.

1. Industry Disrupting Absorption Technology

With their technology, NeutriSci is able to increase the bioavailability of CBD (116%) in the human body. Do not be fooled by statements made by other companies that claim that they have increased it by thousands of percent in the bloodstream. Bloodstream levels and bioavailability absorption are totally different things, the key is bioavailability. In a nutshell, let's call it a blood-brain delivery technology platform, and in our humble opinion, there is nothing better out there than NeutriSci's technology.

2. Industry Disrupting Water-Soluble Technology

NeutriSci International is the only company in the world that uses a unique distillation process vs. Isolate process to make CBD water-soluble. They call it Cryolization, and the patents are filed and pending. There are many companies in the industry claiming that their products are 100% water-soluble, but we have taken a look at other products and technologies and fail to see complete solubility. The fact is that they are not fully water-soluble, and it is a huge problem for the CBD beverage industry. Having a grainy, powdery substance left behind in a solution will receive negative feedback from consumers.


3. Technology: Industry Challenge & Solution Explained


Glen Rehman, CEO of NeutriSci International about the Technology


Glen Rehman, CEO of NeutriSci International ( TSX-V:NU )

“We have given live demonstrations of our technology and formulated products in front of the CEO’s of CBD related companies and they could not believe their eyes when they saw the results.


We can make their products more effective, sharply increase bioavailability, flavor mask their products, make their products fully water soluble either transparent or non-transparent, even flavorless if they want and the best part is we can save these guys money as well.”


He claims that NeutriSci is now in the process of accepting purchase orders as the new state-of-the-art facility is up and running, and he feels very confident about the future of NeutriSci's impact on the industry. In regards to marketing, he believes that one major client utilizing their technology will attract other clients and establish their technology as the gold standard in the industry.


Furthermore, he added that NeutriSci is offering a one-shop solution for its B2B clients. They will formulate the product, manufacture it, package it, and ship it straight to the desired retail outlets. He said that they have been working relentlessly on the technology for years, and now, it is time to reap the benefits.



WATCH THIS LIVE DEMONSTRATION VIDEO


This video was released today. You must watch this video, for it shows how NeutriSci International's superior technology could be crushing the competition in the years to come. It clearly demonstrates that NeutriSci's technology is the future of the CBD beverage industry.


Huge CBD Beverage Contract Around The Corner?


We have checked their recent fillings from last week and discovered that the company is hinting at an order of 1,000,000 units, (initial order 500,000 units + 500,000 units follow up) which has been received by NeutriSci's Joint Venture partner PacWest Manufacturing Group, we are assuming that it will be a CBD beverage line. The new acquisition of the bottling assembly line, therefore makes sense and reaffirms to us that there is a major potential contract coming.


Source: https://www.sedar.com/DisplayCompanyDocuments.dolang=EN&issuerNo=00015938 / MD&A DOC, Page 3

Investment Highlights


Industry Disruptor for CBD, Nutraceutical, & Pharmaceutical industry.

Innovative CBD, CBN, Hemp Product Pipeline.

High Margin Business with own state-of-the-art manufacturing facility.

Exclusive 5 year deal with Tabletz, LLC., Japan's first mover in CBD tablets.

Multiple granted and pending patents; Big potential for licensing deals.

Upcoming expansion into the CBD beverage market.

Competitive advantage: Less CBD extract required, big savings.

Unknown and undervalued company; Huge potential for discovery.

Examples of current product B2B portfolio

Product Assortment of THC and CBD Products
Examples of current product B2B portfolio, Source: NeutriSci Int. Page 15 Investors Deck

NeutriSci International provides a wide service of B2B services for CBD and Nutraceuticals. The company excels in the production of tablets and powders and is expected to strongly expand into the beverage market.


NeutriSci International's Expansion Into Japan


Tabletz, LLC. is the first company to market CBD in the form of tablets in Japan. The company has received approval from the Ministry of Health in Japan; furthermore, it has also received HS Code Clearance by Japanese Customs. NeutriSci International manufactures their entire CBD product line in the United States and exports it directly to Japan. NeutriSci has a 5 year exclusive agreement with Tabletz.

Masa Ikeda, CEO, of Tabletz anticipates his company to become one of the Top 3 CBD brands in Japan because their products will be distributed through Japan's largest drug and supermarket chains. The company has placed a multi million dollar purchase order with NeutriSci international (The full amount has not been disclosed yet by either party, we can not wait to see the actual figure behind the supposedly multi million dollar contract). He claims that the initial feedback is better than expected from their B2B distribution partners and therefore Tabletz has worked out a subscription agreement and an additional bulk version for their products.



Future Product Portfolio & Business Strategy

As seen in the video above, it is obvious that NeutriSci International will excel in the CBD beverage market, for it's technology surpasses those of the competitors. The recent acquisition of their bottling assembly line indicates to us that they are confident in their expansion into the beverage market and expects major contracts to follow. We also believe that the company will come up with CBD related powder products that can be mixed with the consumers beverage of choice, this will probably be sold in form of powder sachets.

Current & Future Developments Source: NeutriSci Int. Page 16 Investors Deck

State - Of - The - Art B2B Manufacturing Facility


NeutriSci International & PacWest Manufacturing Group have invested heavily into their state-of-the-art production facilities. Recently, a new bottling assembly line was ordered that has a capacity of 105,000 bottles per day (35,000 units per shift). Furthermore, 540,000 tablets and 195,000 sachets can be produced per day giving the company a wide B2B spectrum of products. Looks to us that they have put everything into place they need to take on the market.



Our Conclusion


After thorough evaluation of NeutriSci International, we believe that this company is a diamond in the rough. They are completely unknown, undervalued, and poised to disrupt the CBD industry with their astounding technology. The evidence is clear as provided above. This underdog is one major client away from becoming the Gold Standard for the Cannabinoid Industry. You have to understand that this company has spend years and millions of dollars on research and development to get their technology where it is today, now it is time to reap in the benefits and unleash their amazing IP onto the market.


The best part is that they are ready to start commercialization immediately, everything has been put into place, they now have their manufacturing facility, machines, bottling assembly lines, and laboratory where they can formulate, design and produce for their B2B clients in house. Due to their technology, their clients will enjoy considerable savings, as they require less CBD extract to reach maximum bioavailability on their products. Ladies and Gentlemen, those who are able to control cost in the cannabinoid industry will be able to survive and prosper at the end.


Further the company is lined up to become the exclusive manufacturer of Japans upcoming potential top three CBD brands, securing recurring revenues for years to come. Another wildcard that we are paying attention to is their IP, if they receive the patent approval on their unique Cryolization Technology, the market capitalization of NeutriSci should benefit greatly. Taking the Investment Highlights one more time into consideration: Industry Disruptor for CBD, Nutraceutical, & Pharmaceutical industry.

Innovative CBD, CBN, Hemp Product Pipeline.

High Margin Business with own state-of-the-art manufacturing facility.

Exclusive 5 year deal with Tabletz, LLC., Japan's first mover in CBD tablets.

Multiple granted and pending patents; Big potential for licensing deals.

Upcoming expansion into the CBD beverage market.

Competitive advantage: Less CBD extract required, big savings.

Unknown and undervalued company; Huge potential for discovery.


We anticipate that NeutriSci International has the potential for exponential revenue growth in the very near future. Trading at just $0.16 CAD, market capitalization of less than $25 million CAD, an absolute bargain deal for any investor. We strongly believe that the share price has the potential to march to $1.00 CAD by the end of the year.


Sources & References

We urge everyone to do their own thorough research on NeutriSci International and seek professional investment advice before making any investment decision. We have put together a few sources to help you with your research.


1) NeutriSci International Website: www.neutrisci.com

2) NeutriSci International Youtube Channel: https://www.youtube.com/channel/UCfaK3X2knC3DUw9yxh7dX2w

3) NeutriSci International Investors Deck: https://www.neutrisci.com/wp-content/uploads/2021/04/Neutrisci-Corporate-Deck-April-29-Small-File.pdf

4) NeutriSci International Technology Video: https://www.youtube.com/watch?v=Za3fNSEIYjo

5) NeutriSci International Twitter:

https://twitter.com/neutrisci?lang=en

6) Articles About NeutriSci International: https://equity.guru/2021/05/28/neutrisci-international-nu-v-completes-rd-for-cbd-beverage/

7) Articles About NeutriSci International:

https://www.bnnbloomberg.ca/why-neutrisci-s-revamped-strategy-is-the-company-s-holy-grail-1.1425485

8) Tabletz LLC, Website: https://tabletz-cbd.com/

9) NeutriSci TSX Sedar filings: https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00015938

10) Financial Post: https://financialpost.com/business-trends/why-neutrisci-is-well-positioned-to-grow-along-with-the-rapidly-expanding-cbd-space 11) NeutriSci International Patent:

https://patents.justia.com/assignee/neutrisci-international-inc

12) NeutriSci OTC Listing: https://www.otcmarkets.com/stock/NRXCF/overview

13) NeutriSci TSX Venture Listing:

https://money.tmx.com/en/quote/NU

14) NeutriSci Frankfurt Listing:

https://www.boerse-frankfurt.de/equity/neutrisci-intl


Disclaimer


Please note that PRC Partners is a shareholder of NeutriSci International (NU.V) and therefore a conflict of interest exists. PRC Partners is not a financial advisor. Please consult a financial advisor before making any investment decisions. PRC Partners is not being payed or compensated for this for this article. Please read our full disclaimer.



662 views